Consultomics SRL
Consultomics reported total assets of 73,481 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of Consultomics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Consultomics's annual accounts
| 2025 | |
|---|---|
| Net result | 27,193 € |
| Equity | 28,527 € |
| Cash | 3,548 € |
| EBITDA | 34,305 € |
| Total assets | 73,481 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
Consultomics's financial analysis
- Solvency38.8%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Consultomics
Consultomics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1031.104.555
- VAT number
- BE1031104555
- Peppol
- Registered · 0208:1031104555 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Dec 2025
- Registered office
- 3001 Leuven
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Consultomics (SRL) has been based in Leuven since 2025, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 27,193 € and equity of 28,527 €; its revenue is not published. Its solvency stands at 38.8%, below the median of its sector (60.4%).
Companies similar to Consultomics
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- Laboratoire Avédis Research and experimental development on natural sciences and engineering Walhain · balance sheet 72,270 €
- SAB Diagnostics Research and experimental development on natural sciences and engineering Woluwe-Saint-Lambert · balance sheet 72,130 €
- GDP Health Research and experimental development on natural sciences and engineering Lasne · balance sheet 70,909 €
- BMRF Consult Research and experimental development on natural sciences and engineering Trooz · balance sheet 63,686 €
- ADBDL Médecine et Sciences médicales Research and experimental development on natural sciences and engineering Wavre · balance sheet 85,668 €
- Novocure Belgium Research and experimental development on natural sciences and engineering Saint-Josse-ten-Noode · balance sheet 85,983 €
- Docteur Paolo Battisti Research and experimental development on natural sciences and engineering Clavier · balance sheet 86,909 €
Frequently asked questions about Consultomics
What is the revenue of Consultomics?
Consultomics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Consultomics?
In Belgium, the VAT number is the company number prefixed with BE: BE1031104555 for Consultomics, if the company is VAT-registered. Its company number (CBE) is 1031.104.555.
Where is the registered office of Consultomics?
According to the CBE register, the registered office of Consultomics is in 3001 Leuven.
What is the equity of Consultomics?
At the close of the 2025 financial year, the equity of Consultomics amounts to 28,527 €, a solvency of 38.8% of total assets.
Who manages Consultomics?
The register lists 1 active mandates at Consultomics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Consultomics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →